James A Whitlock

5PUBLICATIONS
31CO-AUTHORS
Adolescent healthMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 25, 2026
Asparaginase activity levels and toxicity in children and adolescents with acute lymphoblastic leukemia.

|Feb 24, 2024
Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada.

Sandra Judd, Gabriel Revon-Riviere, Stephanie A Grover

|May 31, 2023
Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse.

Laura E Hogan, Patrick A Brown, Lingyun Ji

|Mar 08, 2023
Dabrafenib, alone or in combination with trametinib, in BRAF V600-mutated pediatric Langerhans cell histiocytosis.

James A Whitlock, Birgit Geoerger, Ira J Dunkel

|Nov 14, 2022
Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric <i>BRAF</i> V600-Mutant Low-Grade Glioma.

Eric Bouffet, Birgit Geoerger, Christopher Moertel

Pageof 1

Frequent Collaborators

1 joint publications

Eric Bouffet

1 joint publications

Birgit Geoerger

1 joint publications

Darren Hargrave

1 joint publications

Mark Russo